Successful Treatment of Bacteremia Due to NDM-1-Producing Morganella morganii with Aztreonam and Ceftazidime-Avibactam Combination in a Pediatric Patient with Hematologic Malignancy
Author(s) -
Claire Amaris Hobson,
Stéphane Bonacorsi,
Mony Fahd,
André Baruchel,
Aurélie Cointe,
Nora Poey,
Hervé Jacquier,
C. Doit,
Audrey Monjault,
Olivier Tenaillon,
André Birgy
Publication year - 2018
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02463-18
Subject(s) - morganella morganii , aztreonam , ceftazidime/avibactam , bacteremia , medicine , ceftazidime , intensive care medicine , microbiology and biotechnology , antibiotics , enterobacteriaceae , biology , bacteria , pseudomonas aeruginosa , biochemistry , genetics , escherichia coli , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom